Clinical Trial Update: Trientine Hydrochloride for the Prevention of Macular Edema Associated With Pan-retinal Photocoagulation for Severe Non-proliferative and Proliferative Diabetic Retinopathy [NA]

View source ↗

Summary

A terminated clinical trial assessing trientine hydrochloride for prevention of macular edema after pan-retinal photocoagulation in severe non-proliferative and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Retinopathy

Drugs mentioned

• TRIENTINE HYDROCHLORIDE (Trientine hydrochloride)

Snippet

Sponsor: University of British Columbia | Conditions: Diabetic Retinopathy | NA | Status: TERMINATED